Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2

Conditions

Neuroblastoma 4Multiple Myeloma 2Vaccinia 1Transplant-Related Hematologic Malignancy 1Recurrence 1Prostatic Neoplasms 1Oligodendroglioma 1Neoplasms 1Medulloblastoma 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Kidney Neoplasms 1Hodgkin Disease 1Glioma 1Carcinoma, Hepatocellular 1Brain Neoplasms 1

Interventions

Dexamethasone 114daratumumab 68Lenalidomide 66Bortezomib 55pomalidomide 44carfilzomib 39Cyclophosphamide 33Specimen Handling 30Calcium Dobesilate 30Biopsy 27Magnetic Resonance Spectroscopy 24belantamab mafodotin 20isatuximab 19fludarabine 17talquetamab 16iberdomide 15Melphalan 15dexamethasone acetate 13dexamethasone 21-phosphate 13auricularum 13fludarabine phosphate 11selinexor 10elotuzumab 10tocilizumab 9X-Rays 8Nivolumab 8Sirolimus 7trametinib 6Whole-Body Irradiation 6Mycophenolic Acid 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Multiple Myeloma × Granulocyte-Macrophage Colony-Stimulating Factor × 90 days × Clear all
NCT07377435 2026-05-08

DC/MM Fusion Vaccine With BCMA CAR-T in R/R MM

Beth Israel Deaconess Medical Center

Phase 1 Recruiting
25 enrolled
Plasma cell

Multiple Myeloma

NCT06799026 2026-05-07

A Phase 1 Study of Vaccination With Dendritic Cell (DC)/Multiple Myeloma (MM) Fusions in Combination With Elranatamab in Relapsed or Refractory Multiple Myeloma

Beth Israel Deaconess Medical Center

Phase 1 Recruiting
25 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡